Metamizole-d3 (sodium salt)
(Synonyms: Dipyrone-d3) 目录号 : GC47639A neuropeptide with diverse biological activities
Cas No.:2512223-60-6
Sample solution is provided at 25 µL, 10mM.
Metamizole-d3 is intended for use as an internal standard for the quantification of metamizole by GC- or LC-MS. Metamizole is a nonopioid prodrug that is rapidly hydrolyzed to the analgesic and antipyretic metabolites 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA).1 It inhibits COX-1 and COX-2 activity (IC50 = ~150 µg/ml for both in cell-free assays), as well as reduces increases in intracellular calcium levels induced by the TRPA1 agonist AITC in isolated rat and mouse dorsal root ganglia and IMR-90 human fibroblasts (IC50s = 30-91 µM in patch-clamp assays).2,3 Metamizole (6, 12, and 25 µg/ml) inhibits ADP- and epinephrine-induced platelet aggregation in human platelet-rich plasma (hPRP).4 It prevents fever induced by LPS, TNF-α, and IL-6, but not arachidonic acid or prostaglandin E2 , in rats when administered at a dose of 120 mg/kg.5 Metamizole (250 and 500 mg/kg) increases the paw withdrawal threshold in the paw pressure test, indicating analgesic activity, in rat models of carrageenan-induced acute pain and postoperative incision pain.6
1.Rogosch, T., Sinning, C., Podlewski, A., et al.Novel bioactive metabolites of dipyrone (metamizol)Bioorg. Med. Chem.20(1)101-107(2012) 2.Campos, C., de Gregorio, R., GarcÍa-Nieto, R., et al.Regulation of cyclooxygenase activity by metamizolEur. J. Pharmacol. 378(3)339-347(1999) 3.Nassini, R., Fusi, C., Materazzi, S., et al.The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivativesBr. J. Pharmacol.172(13)3397-3411(2015) 4.Papp, J., Sandor, B., Vamos, Z., et al.Antiplatelet effect of acetylsalicylic acid, metamizole and their combination - in vitro and in vivo comparisonsClin. Hemorheol. Microcirc. 56(1)1-12(2014) 5.De Souza, G.E.P., Cardoso, R.A., Melo, M.C.C., et al.A comparative study of the antipyretic effects of indomethacin and dipyrone in ratsInflamm. Res. 51(1)24-32(2002) 6.Ince, I., Aksoy, M., Ahiskalioglu, A., et al.A comparative investigation of the analgesic effects of metamizole and paracetamol in ratsJ. Invest. Surg. 28(3)173-180(2015)
Cas No. | 2512223-60-6 | SDF | |
别名 | Dipyrone-d3 | ||
Canonical SMILES | [O-]S(CN(C([2H])([2H])[2H])C1=C(C)N(C)N(C2=CC=CC=C2)C1=O)(=O)=O.[Na+] | ||
分子式 | C13H13D3N3O4S.Na | 分子量 | 336.4 |
溶解度 | DMSO: soluble,Methanol: soluble | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.9727 mL | 14.8633 mL | 29.7265 mL |
5 mM | 0.5945 mL | 2.9727 mL | 5.9453 mL |
10 mM | 0.2973 mL | 1.4863 mL | 2.9727 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet